LSCA Event – From R&D to Market

As biotech companies approach their first commercial launch, CRM and Digital Asset Management (DAM) is often treated as a technology decision.

In practice, the more important challenge is designing the commercial operating model that the technology needs to support.

In this session, ProMeasure will explore the key decisions companies should make before selecting and implementing CRM & DAM: how the commercial model shapes processes and capabilities, why data and governance need to be established early, and how to build an operating model that can scale as the organisation grows.

Drawing on practical experience from life sciences launches, the session will show why commercial operating model first, data and processes before technology, and governance before scaling provide a stronger foundation for launch readiness.